Aza Metal Complexes for MRI Contrast Agents

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional gadolinium complexes used as MRI contrast agents do not adequately utilize the T1-reducing effect of gadolinium ions due to insufficient coordination, leading to reduced image contrast.

Innovation Solution

A metal complex is developed with a cyclic structure that coordinates gadolinium ions more effectively, utilizing a compound represented by Formula (A) with specific side chains and repeating units to enhance T1-reducing ability, resulting in an improved MRI contrast agent.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a gadolinium complex is formed with 7 or 8 coordinating functional groups (conventional ligand structure), then the complex is stable and safe for use, but the T1-reducing ability is insufficient due to inadequate coordination geometry

Engineering Contradiction:
Improvecomplex stabilityVSAvoidT1-reducing ability
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent changes the coordination geometry parameter from conventional 7- or 8-coordinate structures to a 9-coordinate geometry by designing ligands with specific macrocyclic structures and pendant arms that provide exactly 9 coordination sites for the gadolinium ion, thereby optimizing the T1-reducing ability while maintaining complex stability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite coordination structure combining a macrocyclic ligand framework with additional pendant coordinating groups, forming a hybrid ligand system that provides both the stability of macrocyclic chelation and the enhanced T1 effect of 9-coordinate geometry

Inventive Principle:
Principle #40Composite materials

2Ease of manufacture

If Gd3+ is coordinated in a nine-coordination geometry, then the T1-reducing ability is maximized, but the ligand structure becomes more complex

Engineering Contradiction:
ImproveT1-reducing abilityVSAvoidligand structure complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent divides the ligand into functional segments: a macrocyclic core structure that provides 4-5 coordination sites, and pendant arms that provide additional 4-5 coordination sites, totaling 9 coordination sites. This segmentation allows systematic design of the 9-coordinate geometry while managing structural complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent designs the macrocyclic ligand framework to serve multiple functions: providing coordination sites for gadolinium, ensuring complex stability, and enabling the 9-coordinate geometry. The same macrocyclic core can be modified with different pendant arms to achieve various 9-coordinate configurations

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new metal complex demonstrates superior T1-reducing effects compared to conventional agents, enhancing image contrast and stability, as evidenced by increased T1 relaxation times and improved MRI image quality.

Implementation Method 1

a complex (hereinafter referred to as a 'gadolinium complex'), which is stabilized by coordinating an organic ligand to a gadolinium ion

Methodology Applied
Scientific EffectCoordination: Chemical Bonding

Implementation Method 2

Magnetic resonance imaging (MRI) is a method for obtaining an image of a tissue or structure or the like in the living body using nuclear magnetic resonance in a magnetic field

Methodology Applied
Scientific EffectNuclear magnetic resonance:

Data Source

PatentUS9115153B2Aza metal complexes
Publication Date: 2015.08.25 WALMART INC
  • US9115153B2 patent drawing
  • US9115153B2 patent drawing
  • US9115153B2 patent drawing

AI summary

A core of a cyclic structure represented by (—N—(CH2)n—)k is bonded to a dendrimer-type side chain with a specific branched structure at all nitrogen atoms in the core to produce a compound with a specific structure for producing a metal complex that exhibits a T1-reducing effect, and the resulting compound is coordinated to a metal ion that has a T1-reducing effect to obtain a metal complex that exhibits an excellent T1-reducing effect which is useful as an effective component of an MRI contrast agent and an MRI contrast agent using the same.